College of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia.
Thoracic Surgery & Lung Transplant, Lung Health Centre, Organ Transplant Center of Excellence (OTCoE), King Faisal Specialist Hospital & Research Center, Riyadh 11211, Saudi Arabia.
Curr Oncol. 2024 Oct 17;31(10):6232-6244. doi: 10.3390/curroncol31100464.
Artificial intelligence (AI) is increasingly becoming integral to medical practice, potentially enhancing outcomes in thoracic surgery. AI-driven models have shown significant accuracy in diagnosing non-small-cell lung cancer (NSCLC), predicting lymph node metastasis, and aiding in the efficient extraction of electronic medical record (EMR) data. Moreover, AI applications in robotic-assisted thoracic surgery (RATS) and perioperative management reveal the potential to improve surgical precision, patient safety, and overall care efficiency. Despite these advancements, challenges such as data privacy, biases, and ethical concerns remain. This manuscript explores AI applications, particularly machine learning (ML) and natural language processing (NLP), in thoracic surgery, emphasizing their role in diagnosis and perioperative management. It also provides a comprehensive overview of the current state, benefits, and limitations of AI in thoracic surgery, highlighting future directions in the field.
人工智能(AI)正日益成为医疗实践不可或缺的一部分,有可能提高胸外科的治疗效果。人工智能驱动的模型在诊断非小细胞肺癌(NSCLC)、预测淋巴结转移以及辅助电子病历(EMR)数据的有效提取方面表现出了显著的准确性。此外,人工智能在机器人辅助胸外科手术(RATS)和围手术期管理中的应用显示出了提高手术精度、患者安全和整体护理效率的潜力。尽管有这些进展,但数据隐私、偏见和伦理问题等挑战依然存在。本文探讨了人工智能在胸外科中的应用,特别是机器学习(ML)和自然语言处理(NLP),强调了它们在诊断和围手术期管理中的作用。它还全面概述了人工智能在胸外科中的现状、益处和局限性,突出了该领域的未来发展方向。